| Identification | Back Directory | [Name]
ALG1001 | [CAS]
1307293-62-4 | [Synonyms]
ALG1001 Risuteganib ALG1001
(Risuteganib L-Proline, glycyl-L-arginylglycyl-3-sulfo-L-alanyl-L-threonyl- | [Molecular Formula]
C22H39N9O11S | [MDL Number]
MFCD30747849 | [MOL File]
1307293-62-4.mol | [Molecular Weight]
637.66 |
| Hazard Information | Back Directory | [Uses]
Risuteganib is a synthetic RGD (arginyl-glycyl-aspartic acid)-class peptide. Risuteganib is an anti-integrin that downregulates oxidative stress and restores homeostasis, and targets three integrin receptors that are implicated in dry age-related macular degeneration (AMD) in order to restore homeostasis in the retina[1]. | [storage]
Store at -20°C | [References]
[1] Nebbioso M, et al. Therapeutic Approaches with Intravitreal Injections in Geographic Atrophy Secondary to Age-Related Macular Degeneration: Current Drugs and Potential Molecules. Int J Mol Sci. 2019 Apr 4;20(7). pii: E1693. DOI:10.3390/ijms20071693 |
|
| Company Name: |
BOC Sciences
|
| Tel: |
|
| Website: |
https://www.bocsci.com |
|